Cargando…
Novel amodiaquine derivatives potently inhibit Ebola virus infection
Ebola virus disease is a severe disease caused by highly pathogenic Ebolaviruses. Although it shows a high mortality rate in humans, currently there is no licensed therapeutic. During the recent epidemic in West Africa, it was demonstrated that administration of antimalarial medication containing am...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374029/ https://www.ncbi.nlm.nih.gov/pubmed/30395872 http://dx.doi.org/10.1016/j.antiviral.2018.10.025 |